Testicular function after radioiodine therapy in patients with thyroid cancer

Thyroid

Volumn 16, Issue 7, 2006, Pages 667-670

  Rosário, Pedro Weslley Souza ^a,c   Barroso, Álvaro L ^b   Rezende, Leonardo L ^b   Padrão, Eduardo L ^b   Borges, Michelle A R ^a   Guimarães, Valéria C ^a   Purisch, Saulo ^a  

^a Endocrinology Service   (Brazil)

^b Nuclear Medicine Service   (Brazil)

^c Centro de Estudos e Pesquisa da Clinica de Endocrinologia e Metabologia CEPCEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; IODINE 131; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OLIGOSPERMIA; PELVIS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIOIODINATION; SPERM PRESERVATION; SPERMIOGRAM; TESTIS FUNCTION; THYROID CARCINOMA;

ADULT; AGE FACTORS; AGED; FOLLICLE STIMULATING HORMONE; HUMANS; IODINE RADIOISOTOPES; LUTEINIZING HORMONE; MALE; MIDDLE AGED; SPERMATOZOA; TESTIS; TESTOSTERONE; THYROID NEOPLASMS;

EID: 33747337498     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.667     Document Type: Article

References (14)

1. Schlumberger MJ 1998 Medical progress-Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
2. Wichers M, Benz E, Palmedo H, Biersack HJ, Grunwald F, Klingmuller D 2000 Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med 27:503-507.
3. Handelsman DJ, Turtle JR 1983 Testicular damage after radioactive iodine (1-131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 18:465-472.
4. Hyer S, Vini L, O'Connell M, Pratt B, Harmer C 2002 Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 56:755-758.
5. Pacini F, Gasperi M, Fugazzola L, Ceccarelli C, Lippi F, Centoni R, Martino E, Pinchera A 1994 Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med 35:1418-1422.
6. Handelsman DJ, Conway AJ, Donnelly PE, Turtle RJ 1980 Azoospermia after iodine 131 treatment of thyroid cancer. BMJ 281:1527.
7. Andersson AM, Petersen JH, Jorgensen N, Jensen TK, Skakkebaek NE 2004 Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: Significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab 89:2873-2879.
8. Muller HL, Klinkhammer-Schalke M, Seelbach-Goebel B, Hartmann AA, Kuhl J 1996 Gonadal function of young and adults after therapy of malignancies during childhood or adolescence. Eur J Pediatr 155:763-769.
9. Ceccarelli C, Battisti P, Gasperi M, Fantuzzi E, Pacini F, Gualdrini G, Pierantoni MC, Luciani A, Djokich D, Pinchera A. 1999 Radiation dose to the testes after 131 I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer. J Nucl Med 40:1716-1721.
10. Lushbaugh CC, Casarett GW 1976 The effects of gonadal irradiation in clinical radiation therapy: A review. Cancer 37:1111-1120.
11. 131I in the treatment of thyroid cancer. Thyroid Today 16:1-9.
12. Giagulli VA, Vermeulen A 1988 Leydig cell function in infertile men with idiopathic oligospermic infertility. J Clin Endocrinol Metab 66:62-67.
13. Mazzaferri EL, Kloos R 2001 Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463.
14. Wartosfky L 2000 Thyroid Cancer. Humana Press, Totowa, New Jersey.